These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7526402)

  • 41. Characterization of an intronic enhancer that regulates myelin proteolipid protein (Plp) gene expression in oligodendrocytes.
    Meng F; Zolova O; Kokorina NA; Dobretsova A; Wight PA
    J Neurosci Res; 2005 Nov; 82(3):346-56. PubMed ID: 16155935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of myelination in the developing zebrafish.
    Brösamle C; Halpern ME
    Glia; 2002 Jul; 39(1):47-57. PubMed ID: 12112375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice.
    Johnson RS; Roder JC; Riordan JR
    J Neurochem; 1995 Mar; 64(3):967-76. PubMed ID: 7532214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myelin proteolipid DM20: evidence for function independent of myelination.
    Nadon NL; Miller S; Draeger K; Salvaggio M
    Int J Dev Neurosci; 1997 Jun; 15(3):285-93. PubMed ID: 9253653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Developmental expression of proteolipid protein and DM20 mRNAs and proteins in the rat brain.
    LeVine SM; Wong D; Macklin WB
    Dev Neurosci; 1990; 12(4-5):235-50. PubMed ID: 1705207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration.
    Zöller I; Meixner M; Hartmann D; Büssow H; Meyer R; Gieselmann V; Eckhardt M
    J Neurosci; 2008 Sep; 28(39):9741-54. PubMed ID: 18815260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteolipid protein interactions in transfectants: implications for myelin assembly.
    Sinoway MP; Kitagawa K; Timsit S; Hashim GA; Colman DR
    J Neurosci Res; 1994 Apr; 37(5):551-62. PubMed ID: 7518004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subtle myelin defects in PLP-null mice.
    Rosenbluth J; Nave KA; Mierzwa A; Schiff R
    Glia; 2006 Aug; 54(3):172-82. PubMed ID: 16802387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin.
    Nave KA; Lai C; Bloom FE; Milner RJ
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5665-9. PubMed ID: 2441390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteolipid proteins: structure and genetic expression in normal and myelin-deficient mutant mice.
    Nave KA; Milner RJ
    Crit Rev Neurobiol; 1989; 5(1):65-91. PubMed ID: 2670252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transgenic systems in studying myelin gene expression.
    Ikenaka K; Kagawa T
    Dev Neurosci; 1995; 17(3):127-36. PubMed ID: 8549424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abnormal compact myelin in the myelin-deficient rat: absence of proteolipid protein correlates with a defect in the intraperiod line.
    Duncan ID; Hammang JP; Trapp BD
    Proc Natl Acad Sci U S A; 1987 Sep; 84(17):6287-91. PubMed ID: 3476944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteolipid protein: is it more than just a structural component of myelin?
    Knapp PE
    Dev Neurosci; 1996; 18(4):297-308. PubMed ID: 8911768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Focused ion beam-scanning electron microscopy links pathological myelin outfoldings to axonal changes in mice lacking Plp1 or Mag.
    Steyer AM; Buscham TJ; Lorenz C; Hümmert S; Eichel-Vogel MA; Schadt LC; Edgar JM; Köster S; Möbius W; Nave KA; Werner HB
    Glia; 2023 Mar; 71(3):509-523. PubMed ID: 36354016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-mediated excitotoxic axonal damage is attenuated in the absence of myelin proteolipid protein.
    Fowler JH; Edgar JM; Pringle A; McLaughlin M; McCulloch J; Griffiths IR; Garbern JY; Nave KA; Dewar D
    J Neurosci Res; 2006 Jul; 84(1):68-77. PubMed ID: 16625661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Axon myelination. Myelination without myelin-associated glycoprotein.
    Meyer-Franke A; Barres B
    Curr Biol; 1994 Sep; 4(9):847-50. PubMed ID: 7529638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis.
    Mathisen PM; Kawczak JA; Yu M; Johnson JM; Tuohy VK
    J Neurosci Res; 2001 Jun; 64(5):542-51. PubMed ID: 11391709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteolipid protein is necessary in peripheral as well as central myelin.
    Garbern JY; Cambi F; Tang XM; Sima AA; Vallat JM; Bosch EP; Lewis R; Shy M; Sohi J; Kraft G; Chen KL; Joshi I; Leonard DG; Johnson W; Raskind W; Dlouhy SR; Pratt V; Hodes ME; Bird T; Kamholz J
    Neuron; 1997 Jul; 19(1):205-18. PubMed ID: 9247276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of rumpshaker phenotype with wild-type PLP/DM20 suggests several pathogenic mechanisms.
    Barrie JA; Montague P; Karim S; Kirkham D; Nave KA; Anderson TJ; Griffiths IR; McLaughlin M
    J Neurosci Res; 2010 Aug; 88(10):2135-45. PubMed ID: 20175203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Normal metabolism but different physical properties of myelin from mice deficient in proteolipid protein.
    Jurevics H; Hostettler J; Sammond DW; Nave KA; Toews AD; Morell P
    J Neurosci Res; 2003 Mar; 71(6):826-34. PubMed ID: 12605409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.